Protein–protein interaction network analysis and gene set enrichment analysis in epilepsy patients with brain cancer

Many patients with brain cancer experience seizures or epilepsy and tumor-associated epilepsy (TAE) significantly decreases their quality of life. This study aimed to achieve a better understanding of the mechanisms of TAE. The differentially expressed genes (DEG) between epilepsy patients with or without brain tumor were firstly screened using the Linear Models for Microarray Data package using GSE4290 datasets from the USA National Center for Biotechnology Information Gene Expression Omnibus database. Then the protein-protein interaction (PPI) network, using data from the Human Protein Reference Database and the Biological General Repository for Interaction Datasets, was constructed. For further analysis, the PPI network structure and clusters in this PPI network were identified by ClusterOne. Meanwhile, gene set enrichment analysis was performed to illuminate the biological pathways and processes which generally affect patients with TAE. A total of 5113 DEG were identified and a PPI network, which contained 114 DEG and 21 normal genes, was established. Proteins, which mainly belonged to the mini chromosome maintenance and collagen families, were discovered to be enriched in the three identified clusters in the PPI network. Finally, several biological pathways (including cell cycle, DNA replication and transforming growth factor β1 signaling pathways) and processes (such as nucleocytoplasmic transport, nuclear transport and regulation of phosphorylation) were identified. Proteins in these three clusters may become new targets for TAE treatment. Our results provide some potential underlying biomarkers for understanding the pathogenesis of epilepsy in patients with brain tumor.

[1]  Mitchel S Berger,et al.  Seizure characteristics and control following resection in 332 patients with low-grade gliomas. , 2008, Journal of neurosurgery.

[2]  R. Labat.  Traité akkadien de diagnostics et pronostics médicaux , 1951 .

[3]  D. Scharnweber,et al.  Effect of biological implant surface coatings on bone formation, applying collagen, proteoglycans, glycosaminoglycans and growth factors , 2008, Journal of materials science. Materials in medicine.

[4]  Gary D. Bader,et al.  An automated method for finding molecular complexes in large protein interaction networks , 2003, BMC Bioinformatics.

[5]  Tiejun Li,et al.  Determination of GABAAα1 and GABAB1 receptor subunits expression in tissues of gilts during the late gestation , 2012, Molecular Biology Reports.

[6]  A. Guarné,et al.  Dbf4: The whole is greater than the sum of its parts , 2013, Cell cycle.

[7]  Mark Sherman,et al.  The 2001 Bethesda System: terminology for reporting results of cervical cytology. , 2002, JAMA.

[8]  Amy Freeland,et al.  Reduced Mcm2 Expression Results in Severe Stem/Progenitor Cell Deficiency and Cancer , 2007, Stem cells.

[9]  Jeremy Adler,et al.  Quantifying colocalization by correlation: The Pearson correlation coefficient is superior to the Mander's overlap coefficient , 2010, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[10]  S. Dupont.  Epilepsy and Brain Tumours and Antiepileptic Drugs , 2011 .

[11]  E. Aronica,et al.  Gene expression profile analysis of epilepsy-associated gangliogliomas , 2008, Neuroscience.

[12]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[13]  T. Jiang,et al.  The pathogenesis of tumor-related epilepsy and its implications for clinical treatment , 2012, Seizure.

[14]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[15]  M. Hayat.  Tumors of the Central Nervous System, Volume 1 , 2011 .

[16]  A. Söling,et al.  Minichromosome maintenance protein 3 elicits a cancer-restricted immune response in patients with brain malignancies and is a strong independent predictor of survival in patients with anaplastic astrocytoma. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[17]  C. Pui,et al.  Saving the children--improving childhood cancer treatment in developing countries. , 2005, The New England journal of medicine.

[18]  Hanno Steen,et al.  Development of human protein reference database as an initial platform for approaching systems biology in humans. , 2003, Genome research.

[19]  P. Sahu,et al.  Piperine protects epilepsy associated depression: a study on role of monoamines. , 2011, European review for medical and pharmacological sciences.

[20]  Jayant P. Menon,et al.  Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. , 2006, Cancer cell.

[21]  Tatsuro S. Takahashi,et al.  Mcm10 plays an essential role in origin DNA unwinding after loading of the CMG components , 2012, The EMBO journal.

[22]  L. Truong,et al.  Dbf4 Is Direct Downstream Target of Ataxia Telangiectasia Mutated (ATM) and Ataxia Telangiectasia and Rad3-related (ATR) Protein to Regulate Intra-S-phase Checkpoint* , 2011, The Journal of Biological Chemistry.

[23]  Bruce Stillman,et al.  Cdc7-Dbf4 phosphorylates MCM proteins via a docking site-mediated mechanism to promote S phase progression. , 2006, Molecular cell.

[24]  Harald Sontheimer,et al.  A role for glutamate in growth and invasion of primary brain tumors , 2008, Journal of neurochemistry.

[25]  C. Shafer,et al.  Inhibition of Cdc7/Dbf4 kinase activity affects specific phosphorylation sites on MCM2 in cancer cells , 2008, Journal of cellular biochemistry.

[26]  Mike Tyers,et al.  BioGRID: a general repository for interaction datasets , 2005, Nucleic Acids Res..

[27]  M. Lei,et al.  Initiating DNA synthesis: from recruiting to activating the MCM complex. , 2001, Journal of cell science.

[28]  I. R. Whittle,et al.  The Pathogenesis of Tumour Associated Epilepsy , 2000, Acta Neurochirurgica.

[29]  Kenichi Yoshida,et al.  Identification of a novel cell-cycle-induced MCM family protein MCM9. , 2005, Biochemical and biophysical research communications.

[30]  L. J. Rubinstein,et al.  Tumors of the central nervous system , 1972 .

[31]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[32]  U. Heinemann,et al.  Blood–brain barrier breakdown-inducing astrocytic transformation: Novel targets for the prevention of epilepsy , 2009, Epilepsy Research.

[33]  C. Heldin,et al.  Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. , 2009, Current opinion in cell biology.

[34]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[35]  Gordon K Smyth,et al.  Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2004, Statistical applications in genetics and molecular biology.

[36]  Shawn M. Sweeney,et al.  Mapping the Ligand-binding Sites and Disease-associated Mutations on the Most Abundant Protein in the Human, Type I Collagen* , 2002, The Journal of Biological Chemistry.

[37]  L. Frappier,et al.  Interactions of the Human MCM-BP Protein with MCM Complex Components and Dbf4 , 2012, PloS one.